Evidence map›Paper›PMID 38659788›Full record

ArticleResearch square2024

Venous excess ultrasonography (VExUS) captures dynamic changes in volume status surrounding hemodialysis: A multicenter prospective observational study.

Katarina Leyba, August Longino, Ryen Ormesher, Mary Krienke, Natalie Van Ochten, Katherine Zimmerman, Luke McCormack, Katharine Martin, Theresa Thai, Seth Furgeson and 4 more

Registry-linked trialOpen access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07291778 (The Impact of VeXUS-guided Fluid Management in ICU Populations on Renal Function), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07291778 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Impact of VeXUS-guided Fluid Management in ICU Populations on Renal Function

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2026 to 2028Enrolled100ConditionsAcute Kidney Injury, VExUSArmsFluid Management, No intervention
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Katarina LeybaUniversity of Colorado.
August LonginoUniversity of Colorado.
Ryen OrmesherUniversity of Colorado.
Mary KrienkeUniversity of Colorado.
Natalie Van OchtenUniversity of Colorado.
Katherine ZimmermanUniversity of Colorado.
Luke McCormackUniversity of Colorado.
Katharine MartinUniversity of Colorado School of Medicine.
Theresa ThaiUniversity of Colorado.
Seth FurgesonDenver Health Medical Center.
Isaac TeitelbaumUniversity of Colorado.
Joseph BurkeUniversity of Colorado.
Ivor DouglasDenver Health Medical Center.
Edward GillUniversity of Colorado.
University of Colorado System · USDenver Health Medical Center · USUniversity of Colorado Denver · US

Funding

Colorado StARR Program in Medicine and Pediatrics (CSPMP)R38HL143511 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Steven Herbert Abman, Peter N. Buttrick · 2020 to 2026
$2.7M
NHLBI NIH HHS R38 HL143511
6 · The paper itself

Abstract

Background: The evaluation of volume status is essential to clinical decision-making, yet multiple studies have shown that physical exam does not reliably estimate a patient's intravascular volume. Venous excess ultrasound score (VExUS) is an emerging volume assessment tool that utilizes inferior vena cava (IVC) diameter and pulse-wave Doppler waveforms of the portal, hepatic and renal veins to evaluate venous congestion. A point-of-care ultrasound exam initially developed by Beaubein-Souligny et al., VExUS represents a reproducible, non-invasive and accurate means of assessing intravascular congestion. VExUS has recently been validated against RHC-the gold-standard of hemodynamic evaluation for volume assessment. While VExUS scores were shown to correlate with elevated cardiac filling pressures (i.e., right atrial pressure (RAP) and pulmonary capillary wedge pressure (PCWP)) at a static point in time, the ability of VExUS to capture dynamic changes in volume status has yet to be elucidated. We hypothesized that paired VExUS examinations performed before and after hemodialysis (HD) would reflect changes in venous congestion in a diverse patient population. Methods: Inpatients with end-stage renal disease undergoing intermittent HD were evaluated with transabdominal VExUS and lung ultrasonography before and following HD. Paired t-tests were conducted to assess differences between pre-HD and post-HD VExUS scores, B-line scores and dyspnea scores. Results: Fifty-six patients were screened for inclusion in this study. Ten were excluded due to insufficient image quality or incomplete exams, and forty-six patients (ninety-two paired ultrasound exams) were included in the final analysis. Paired t-test analysis of pre-HD and post-HD VExUS scores revealed a mean VExUS grade change of 0.82 (p<0.001) on a VExUS scale ranging from 0 to 4. The mean difference in B-line score following HD was 0.8 (p=0.001). There was no statistically significant difference in subjective dyspnea score (p=0.41). Conclusions: Large-volume fluid removal with HD was represented by changes in VExUS score, highlighting the utility of the VExUS exam to capture dynamic shifts in intravascular volume status. Future studies should evaluate change in VExUS grade with intravenous fluid or diuretic administration, with the ultimate goal of evaluating the capacity of a standardized bedside ultrasound protocol to guide inpatient volume optimization.

Indexed as

End-stage renal disease (ESRD)hemodialysis (HD)point-of-care ultrasonography (POCUS)venous congestionvenous excess ultrasonography (VExUS)volume status

Identifiers

PMID38659788
PMCPMC11042415
OpenAlexW4394565830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.